Try our Advanced Search for more refined results
Health
-
March 13, 2026
Drug Co. Moves To Sanction Insurer Over Destroyed Evidence
A drug wholesaler seeking coverage for underlying opioid litigation urged an Illinois federal court to sanction its insurer for destroying key emails and underwriting records, saying the carrier failed to update a litigation hold or suspend its automatic deletion policies and then attempted to hide the issue during discovery.
-
March 13, 2026
EPA Aims To Lift Biden-Era Ethylene Oxide Limits
The U.S. Environmental Protection Agency on Friday proposed rolling back limits on emissions of ethylene oxide, a carcinogenic chemical used in the sterilization of medical devices.
-
March 13, 2026
Tort Report: Uber Won't OK Bigger Jury At 2nd Bellwether
Trial strategy by Uber ahead of a second bellwether trial in sexual assault multidistrict litigation and a $4 million injury verdict against Publix in Florida lead Law360's Tort Report, which compiles recent personal injury and medical malpractice news that may have flown under the radar.
-
March 12, 2026
Ariz. Docs Ink $4.75M FCA Deal Over Unnecessary Treatment
An Arizona-based physician group that offers cardiology and vascular services has inked a $4.75 million settlement to resolve False Claims Act allegations they performed unnecessary vein ablations and submitted claims for payment to government healthcare programs for reimbursement, the U.S. Department of Justice said Thursday.
-
March 12, 2026
Top Texas Court Upholds Death Sentence For ICU Nurse
The Texas Court of Criminal Appeals on Thursday affirmed the death sentence of a former cardiovascular nurse convicted of intentionally murdering patients recovering from operations, finding that Texas prosecutors' accusation that defense counsel engaged in "misdirection and deception" was "mild."
-
March 12, 2026
DC Circ. Spends Hours Debating 'Same' Generic Label Reqs
The D.C. Circuit spent more than three hours Thursday going round with Vanda Pharmaceuticals and the U.S. Food and Drug Administration about whether the label for a generic sleep-wake disorder medication is "the same" as the branded one because it doesn't include Braille.
-
March 12, 2026
Wash. Justices OK Jury Instruction In TB Malpractice Case
The Washington State Supreme Court declined Thursday to flip a family's loss in a case blaming an Evergreen State doctor for failing to address signs of an intestinal tuberculosis infection that led to a patient's death, rejecting a challenge to a jury instruction on the physician's exercise of judgment.
-
March 12, 2026
Colo. Panel Clarifies Workers Comp Law On Maintenance Care
In interpreting the Colorado Workers' Compensation Act, the Colorado Court of Appeals ruled for the first time Thursday that employers and their insurers cannot limit maintenance medical benefits to any specific treatment in a final admission of liability.
-
March 12, 2026
Insurer Asks NC Justices To Free It From Captive Carrier Row
A Georgia insurance company told North Carolina's highest court that the state's Business Court doesn't have jurisdiction over it in a shareholder dispute over the demise of a defunct captive insurer, arguing it had nothing to do with the supposed bad acts of its individual members.
-
March 12, 2026
Embryo Loss Suits Need 'Serious' Edits, Judge Told
Two complaints against fertility products maker CooperSurgical Inc. require "serious" amendments to clarify the nature of the claims that a defective culture medium caused embryo losses for in vitro fertilization patients, the company told a Connecticut federal judge Thursday.
-
March 12, 2026
Meta To Face Sanctions Bid Over Addiction MDL Privilege Log
School district plaintiffs and attorneys general have told a California federal judge they plan to seek sanctions against Meta Platforms Inc. in the social media addiction multidistrict litigation for the tech giant's "extremely belated production" of over 73,841 documents downgraded off privilege logs, months after fact discovery closed.
-
March 12, 2026
US Chamber Report Warns Of Risks To IP Protection
While the U.S. has ranked at the top of the U.S. Chamber of Commerce's list measuring how countries worldwide are enforcing intellectual property laws, the group said problems with free trade agreements and efforts to reduce pharmaceutical prices could cause problems on the horizon domestically.
-
March 12, 2026
Idaho Says Director Immune In THC Child Abuse Registry Suit
The director of Idaho Health and Welfare is asking a federal court to throw out claims from two women alleging the state violated their constitutional rights by putting them on the state's child abuse registry for their use of cannabis while pregnant, saying the director is immune and the state's rules satisfy due process.
-
March 12, 2026
NFL Alumni Argues Biotech's Suit Lacks Contractual Basis
The National Football League's largest alumni group is angling to quash a biotech company's breach of contract lawsuit, explaining that details in the suit on the termination of their partnership for a vaccine education program are thin.
-
March 12, 2026
Doc's Hands Aren't Property, Texas Panel Rules In Death Suit
A state-employed doctor's hands are not "tangible personal property," a Texas appeals court ruled Thursday, dismissing a wrongful death suit from the family of a patient who contracted a fatal infection during her hospital stay.
-
March 11, 2026
DNA Testing Co. Can't Shake Suit Over Genetic Data Sharing
A Massachusetts federal judge refused to release Nebula Genomics Inc. from a proposed class action accusing it of illegally sharing its customers' genetic information with Meta and other third parties through online tracking tools, finding that the parties' choice-of-law agreement didn't extend to the plaintiff's genetic privacy allegation.
-
March 11, 2026
Eli Lilly Ordered To Arbitrate Alzheimer's Drug Feud
An Illinois federal judge ordered Eli Lilly and Co. on Tuesday to arbitrate a dispute over millions of dollars in milestone payments allegedly owed under a collaboration agreement to develop an Alzheimer's disease drug, ruling that the drugmaker lacked standing to challenge an underlying security agreement.
-
March 11, 2026
New Wyoming Abortion Law Faces Familiar Legal Challenge
Just a day after it was signed into law, Wyoming's new anti-abortion law triggered a legal challenge from the same health clinic that successfully sued over the state's previous abortion limits.
-
March 11, 2026
La. Fights Dismissal Bid In Abortion Regulation Dispute
The state of Louisiana urged a federal court to deny motions by GenBioPro Inc. and Danco Laboratories seeking dismissal of its suit challenging federal regulation on mail-order abortion drugs, arguing it has established harms stemming from the regulations.
-
March 11, 2026
Ohio Hospital Defeats DaVita's Dialysis Discrimination Suit
An Ohio hospital and its health benefit plan did not discriminate against patients with end-stage renal disease by eliminating in-network coverage for dialysis, a federal court ruled, finding that dialysis provider DaVita Inc. failed to show the plan intended to harm participants.
-
March 11, 2026
Wash. Says ICE Contractor Cannot Defend Barring Inspection
The Washington State Department of Health said a contractor's attempts to escape an evidentiary hearing demonstrated that the company could not defend its jurisdictional claims in a lawsuit accusing it of illegally restricting access to an immigration facility.
-
March 11, 2026
Allstate Says Chiropractors Ran 'Personal Injury Mill'
Allstate told a Texas federal court in a lawsuit seeking at least $25.8 million that two chiropractors and their associated healthcare entities operated a racketeering enterprise to make money from automobile accident personal injury settlements.
-
March 11, 2026
Insulin Makers Ask Justices To Review Collusion Case
Sanofi-Aventis US, Eli Lilly & Co., Novo Nordisk Inc. and AstraZeneca Pharmaceuticals LP have told the U.S. Supreme Court that a ruling reviving a case over insulin drug costs undermines key rules meant to weed out improper antitrust claims.
-
March 11, 2026
Pharma Co. Says Ex-Director Using Trade Secrets At New Job
A specialty infusion therapy pharmacy has accused a former director of contracts of taking valuable trade secrets with her on her way out to work for a rival company.
-
March 11, 2026
VA, DOJ Cut Deal To Make Attys Mental Health Guardians
Under a new initiative, attorneys at the U.S. Department of Justice will serve as legal guardians for some homeless veterans, the Trump administration announced on Wednesday, though some veterans advocates expressed concern that the new program could involuntarily coerce veterans experiencing mental health issues into institutional care.
Expert Analysis
-
What's At Stake In Possible Circuit Split On Medicaid Rule
A recent Eleventh Circuit decision, reviving Florida's lawsuit against a federal rule that reduces Medicaid funding based on agreements between hospitals, sets up a potential circuit split with the Fifth Circuit, with important ramifications for states looking to private administrators to run provider tax programs, say Liz Goodman, Karuna Seshasai and Rebecca Pitt at FTI Consulting.
-
Malpractice Claim Assignability Continues To Divide Courts
Recent decisions from courts across the country demonstrate how different jurisdictions balance competing policy interests in determining whether legal malpractice claims can be assigned, providing a framework to identify when and how to challenge any attempted assignment, says Christopher Blazejewski at Sherin & Lodgen.
-
Courts' Rare Quash Of DOJ Subpoenas Has Lessons For Cos.
In a rare move, three federal courts recently quashed or partially quashed expansive U.S. Department of Justice administrative subpoenas issued to providers of gender-affirming care, demonstrating that courts will scrutinize purpose, cabin statutory authority and acknowledge the profound privacy burdens of overbroad government demands for sensitive records, say attorneys at ArentFox Schiff.
-
Unpacking Dormant Commerce Clause Cannabis Circuit Split
Federal courts have reached differing conclusions as to whether state-legal cannabis is subject to the dormant commerce clause, with four opinions across three circuit courts in the last year demonstrating the continued salience of the dormant commerce clause debate to the nation's cannabis industry, regulators and policymakers, say attorneys at Perkins Coie.
-
Remote Patient Monitoring Is At Regulatory Inflection Point
With remote patient monitoring at the center of new federal pilot programs and a recent report from the U.S. Department of Health and Human Services' Office of Inspector General examining Medicare billing for those services, it is clear that balancing innovation and risk will be a central challenge ahead for digital health stakeholders, say attorneys at Morgan Lewis.
-
Texas AG Wields Consumer Protection Law Against Tech Cos.
Texas Attorney General Ken Paxton has targeted technology companies using the Texas Deceptive Trade Practices Act, a broadly worded statute that gives the attorney general wide latitude to pursue claims beyond traditional consumer protection, creating unique litigation risks, say attorneys at Yetter Coleman.
-
Utah's AI Prescription Renewal Pilot Could Inform Policy
Utah recently became the first state to approve an artificial intelligence system for autonomously renewing certain prescription medicines, providing a test case for how regulators may be able to draw boundaries between administrative automation and medical judgment, say Jashaswi Ghosh at Holon Law Partners and Bryant Godfrey at Foley Hoag.
-
Ramped Up Psychedelic Production Carries Opportunity, Risk
Kimberly Chew at Husch Blackwell discusses the key legal implications of the U.S. Drug Enforcement Administration's recent dramatic increases in the production quotas for a range of psychedelic substances, offering guidance on compliance, risk management and strategic opportunities for practitioners navigating this rapidly evolving landscape.
-
Series
Teaching Logic Makes Me A Better Lawyer
Teaching middle and high school students the skills to untangle complicated arguments and identify faulty reasoning has made me reacquaint myself with the defined structure of thought, reminding me why logic should remain foundational in the practice of law, says Tom Barrow at Woods Rogers.
-
New Biotech Nat'l Security Controls May Have Blunted Impact
While the newly enacted federal prohibition against contracting with certain biotechnology providers associated with countries of concern may have consequences on U.S. companies' ability to develop drugs, the restrictions may prove to be less problematic for the industry than the significant publicity around their passage would suggest, say attorneys at Wilson Sonsini.
-
Series
Law School's Missed Lessons: Practicing Resilience
Resilience is a skill acquired through daily practices that focus on learning from missteps, recovering quickly without internalizing defeat and moving forward with intention, says Nicholas Meza at Quarles & Brady.
-
Takeaways From The DOJ Fraud Section's 2025 Year In Review
Former acting Principal Deputy Chief Sean Tonolli of the U.S. Department of Justice's Fraud Section, now at Cahill Gordon, analyzes key findings from the section’s annual report — including the changes implemented to adapt to the new administration’s priorities — and lays out what to watch for this year.
-
4 Lessons From FTC's Successful Bid To Block Edwards Deal
The Federal Trade Commission's recent victory in blocking Edwards Lifesciences' acquisition of JenaValve offers key insights for deals in life sciences and beyond, including considerations around nonprice dimensions and clear skies provisions, say attorneys at Orrick.
-
Traditional FCA Enforcement Surges Amid Shifting Priorities
The U.S. Department of Justice’s January report on False Claims Act enforcement in fiscal year 2025 reveals that while the administration signaled its intent to expand FCA enforcement into new areas such as tariffs, for now the greatest exposure remains in traditional areas like healthcare — in which the risk is growing, say attorneys at Debevoise.
-
State Of Insurance: Q4 Notes From Illinois
In 2025's last quarter, Illinois’ appellate courts weighed in on overlapping homeowners coverages for water-related damages, contractual suit limitation provisions in uninsured motorist policies, and protections for genetic health information in life insurance underwriting, while the Department of Insurance sought nationwide homeowners' insurance data from State Farm, says Matthew Fortin at BatesCarey.